TrialDrugs in R&D2017

Population Pharmacokinetics and Pharmacodynamics Modelling of Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome.

Shuying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.